These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Matschinsky FM Diabetes; 1996 Feb; 45(2):223-41. PubMed ID: 8549869 [TBL] [Abstract][Full Text] [Related]
23. Identification of eight novel glucokinase mutations in Italian children with maturity-onset diabetes of the young. Mantovani V; Salardi S; Cerreta V; Bastia D; Cenci M; Ragni L; Zucchini S; Parente R; Cicognani A Hum Mutat; 2003 Oct; 22(4):338. PubMed ID: 12955723 [TBL] [Abstract][Full Text] [Related]
24. Maturity onset diabetes of the young (MODY). Fajans SS; Bell GI; Bowden DW; Halter JB; Polonsky KS Diabet Med; 1996 Sep; 13(9 Suppl 6):S90-5. PubMed ID: 8894490 [TBL] [Abstract][Full Text] [Related]
25. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Velho G; Blanché H; Vaxillaire M; Bellanné-Chantelot C; Pardini VC; Timsit J; Passa P; Deschamps I; Robert JJ; Weber IT; Marotta D; Pilkis SJ; Lipkind GM; Bell GI; Froguel P Diabetologia; 1997 Feb; 40(2):217-24. PubMed ID: 9049484 [TBL] [Abstract][Full Text] [Related]
26. Circadian and age-dependent expression patterns of GLUT2 and glucokinase in the pancreatic beta-cell of diabetic and nondiabetic rats. Frese T; Bazwinsky I; Mühlbauer E; Peschke E Horm Metab Res; 2007 Aug; 39(8):567-74. PubMed ID: 17712721 [TBL] [Abstract][Full Text] [Related]
27. Glucokinase (GCK) in diabetes: from molecular mechanisms to disease pathogenesis. Abu Aqel Y; Alnesf A; Aigha II; Islam Z; Kolatkar PR; Teo A; Abdelalim EM Cell Mol Biol Lett; 2024 Sep; 29(1):120. PubMed ID: 39245718 [TBL] [Abstract][Full Text] [Related]
28. Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes. Chow E; Wang K; Lim CKP; Tsoi STF; Fan B; Poon E; Luk AOY; Ma RCW; Ferrannini E; Mari A; Chen L; Chan JCN Diabetes; 2023 Feb; 72(2):299-308. PubMed ID: 36342518 [TBL] [Abstract][Full Text] [Related]
29. [Swiss journey through the clinical and genetic characteristics of diabetes in young patients]. Dussoix P; Tappy L; Philippe J Schweiz Med Wochenschr; 1998 Jan; 128(5):162-6. PubMed ID: 9522422 [TBL] [Abstract][Full Text] [Related]
30. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Owen K; Hattersley AT Best Pract Res Clin Endocrinol Metab; 2001 Sep; 15(3):309-23. PubMed ID: 11554773 [TBL] [Abstract][Full Text] [Related]
31. Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype. Miller SP; Anand GR; Karschnia EJ; Bell GI; LaPorte DC; Lange AJ Diabetes; 1999 Aug; 48(8):1645-51. PubMed ID: 10426385 [TBL] [Abstract][Full Text] [Related]
32. Characterization of two MODY2 mutations with different susceptibility to activation. Langer S; Platz C; Waterstradt R; Baltrusch S Biochem Biophys Res Commun; 2015 Sep; 464(4):1113-1119. PubMed ID: 26208450 [TBL] [Abstract][Full Text] [Related]
33. [MODY, a model of genotype/phenotype interactions in type 2 diabetes]. Velho G; Bellanné-Chantelot C; Timsit J Med Sci (Paris); 2003; 19(8-9):854-9. PubMed ID: 14593617 [TBL] [Abstract][Full Text] [Related]
35. [From gene to disease; 'maturity-onset diabetes of the young' (MODY), monogenetic inheritable forms of diabetes mellitus]. Maassen JA; Lemkes HH; Losekoot M Ned Tijdschr Geneeskd; 2001 Jul; 145(28):1352-3. PubMed ID: 11484433 [TBL] [Abstract][Full Text] [Related]
36. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Yamagata K; Furuta H; Oda N; Kaisaki PJ; Menzel S; Cox NJ; Fajans SS; Signorini S; Stoffel M; Bell GI Nature; 1996 Dec; 384(6608):458-60. PubMed ID: 8945471 [TBL] [Abstract][Full Text] [Related]
37. Nonradioactive screening of glucokinase mutations in maturity onset diabetes of the young. Blanché H; Hager J; Sun F; Dausset J; Cohen D; Froguel P; Cohen N Biotechniques; 1994 May; 16(5):866-8, 870, 873-6. PubMed ID: 8068341 [TBL] [Abstract][Full Text] [Related]
38. Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects. Matschinsky FM; Zelent B; Doliba NM; Kaestner KH; Vanderkooi JM; Grimsby J; Berthel SJ; Sarabu R Handb Exp Pharmacol; 2011; (203):357-401. PubMed ID: 21484579 [TBL] [Abstract][Full Text] [Related]
39. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs. Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519 [TBL] [Abstract][Full Text] [Related]